Craneware Share News (CRW)
CRW Share
CRW Share
CRW Share
CRW Share
CRW
CRW Share
CRW Level 2
CRW Live
CRW Broker
CRW Directors
CRW Financial
CRW
CRW Short
CRW
Last checked at -
US healthcare software developer Craneware said first half trading has been positive as increased levels of sales start to contribute to revenue growth. The group, which provides monitoring and automated revenue systems, said it expects to report revenue growth to $20.1m, up from $18.8m in the same
Read moreAbbey Protection: Numis increases target price from 90p to 120p and upgrades to add. Admiral: Goldman Sachs upgrades to buy from neutral, raising its price target to 1500p from 1160p before. Aggreko: Bank of America lowers target price from 2700p to 1950p and downgrades to neutral. Anglo Americ
Read moreAquarius Platinum: Nomura raises target price from 35p to 95p and upgrades from neutral to buy. Associated British Foods; Societe Generale upgrades to buy from hold. Atkins: Jefferies reduces target price from 850p to 800p, buy recommendation reiterated. Aveva: Panmure Gordon reduces target price
Read moreTwo directors of emerging markets-focused investment group City of London disposed of beneficial interests they have in the company on Wednesday, just two days after the firm's full-year results revealed a large decline in funds under management (FuM). Non-executive director David Cardale and Finan
Read moreAMEC: Nomura retains buy rating and 1,240p target. Ashtead: UBS ups target from 340p to 375p, buy rating unchanged. ASOS: Oriel Securities upgrades to buy; BarCap upgrades to overweight, target lifted rom 1,800p to 2,400p. BP: Investec keeps buy rating and 460p target. BT Group: JPMorgan Cazenov
Read moreUK-listed but US-focused healthcare software provider Craneware is benefiting from the cost pressures on American hospitals. The company, which provides monitoring and automated revenue systems, has reported revenues of $41.1m in the 12 months to the end of June, a rise of 8% on the prior year. Ad
Read moreUS healthcare software developer Craneware said adjusted EBITDA will be below current market expectations for the year. The board expects to report revenue for the year in the region of $41m compared to $38.1m the year before. Adjusted EBITDA rose 15% from the previous year's figure of $10.1m. Thi
Read moreAntofagasta: RBS Capital Markets downgrades to underperform. Ashtead: Jefferies keeps buy recommendation and 300p target. Barclays: Bank of America Merrill Lynch keeps buy rating and 370p target; Oriel Securities reiterates buy recommendation and 285p target. BP: Nomura retains neutral stance and
Read moreThe share price of Craneware took flight and moved away from its 52-week low after the software supplier to the US health-care market announced a new contract win. The deal will see an unnamed "channel supplier" pay Craneware $7.5m between now and June 30th, 2014, in exchange for multi-year licence
Read moreShares in Scotland-based software developer Craneware nose-dived more than 30%, or 170p, after both Investec and Brewin Dolphin downgraded the firm from buy to hold. The brokers' decisions came despite a 12% increase in first half year revenue from $16.6m. The results include, for the first time,
Read moreJohnson Matthey's investors have become accustomed to the company making all the right noises when it updates the market. And yesterday it did not disappoint, writes the Independent. The speciality chemicals operation, which refines platinum and is the world's biggest maker of catalytic converters,
Read moreScotland-based software developer Craneware said revenue for the year ended 30 June 2011 is expected to have grown by 34% from $28.4m in 2010. The group, which provides revenue calculating software to US hospitals, said it is trading in line with company forecasts as it closed the year on strong f
Read moreWill Ethridge, chief executive of Financial Times publisher Pearson's North American education division, has sold a big chunk of shares in the company. He disposed of 33,000 American Depositary Receipts (ADRs) for $16.83 (£1,033p) a time or a total of nearly £350,000. News of the share sale comes
Read moreAnglo-American's chairman Sir John Parker has added to his stake in the company again with the purchase of nearly £100,000 in shares. He bought 2,890 at 3,282.5p a time. Last week he bought 3,000 at 3,238p each. Anglo American announced earlier this month that it is merging its UK cement, aggregat
Read moreScotland-based Craneware, which provides revenue assessing software to US hospitals, continues its impressive growth in the six months to December 2010. AIM-quoted Craneware increased its rate of growth in the first half and continued to generate cash. Revenues grew by one-quarter to $16.6m with
Read more
Last checked at